US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medicus Pharma Ltd.

3.14

+0.09503.13%

Volume:12.61K

Turnover:39.54K

Market Cap:36.76M

PE:- -

High:3.24

Open:3.18

Low:2.86

Close:3.04

Loading ...

Overview Company News Filings

Promising Phase 2 Study and Innovative Approach Boost Confidence in Medicus Pharma Ltd.

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Medicus Pharma enters SEPA, intends to voluntarily delist from TSX

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Medicus Pharma Ltd. Announces Change of Auditor

Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success with Favorable Buy Rating

Medicus Pharma initiated with a Buy at Brookline

Medicus Pharma Eyes Veterinary Market with FDA Designation

Medicus Pharma announcs its INAD received MUMS from U.S. FDA

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

MDCX: Medicus Pharma 3Q 2024 Financial Results Reported; Stock Now Trades Both in Canada and on Nasdaq After Completing an IPO in the U.S.

Zacks Small Cap Research

Medicus Pharma Ltd. Expands with Strategic Takeover

V.MDCX: Medicus Pharma Has Begun Trading on Nasdaq under the ticker MDCX after Completing an IPO in the U.S. The SKNJCT-003 Phase 2 clinical trial continues.

Zacks Small Cap Research

Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Medicus Pharma Closes $4M IPO, Trades on Nasdaq

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/MDCX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":3.135,"timestamp":1742411271604,"preClose":3.04,"halted":0,"volume":12611,"delay":0,"changeRate":0.03125,"change":0.095,"floatShares":4049793,"shares":11726780,"lyrEps":0,"amount":39537.7701132,"amplitude":0.125,"volumeRatio":0.306619,"dividePrice":0,"prevYearClose":2.43,"fiveDayClose":3.29,"twentyDayClose":4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":4049793,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.306619,"shares":11726780,"dividePrice":0,"high":3.24,"amplitude":0.125,"preClose":3.04,"low":2.86,"week52Low":1.8,"pbRate":"--","week52High":4.99,"institutionHeld":0,"latestPrice":3.135,"committee":-0.73913,"eps":0,"divideRate":0,"volume":12611,"delay":0,"ttmEps":0,"open":3.1809,"prevYearClose":2.43,"prevWeekClose":3.29,"prevMonthClose":3.99,"prevQuarterClose":2.43,"fiveDayClose":3.29,"twentyDayClose":4,"sixtyDayClose":2.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1735012800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511220605","title":"Promising Phase 2 Study and Innovative Approach Boost Confidence in Medicus Pharma Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2511220605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511220605?lang=en_us&edition=fundamental","pubTime":"2025-02-16 02:05","pubTimestamp":1739642708,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on Medicus Pharma Ltd (MDCX – Research Report), with a pric...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-2-study-and-innovative-approach-boost-confidence-in-medicus-pharma-ltd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-2-study-and-innovative-approach-boost-confidence-in-medicus-pharma-ltd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2511662136","title":"Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511662136","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511662136?lang=en_us&edition=fundamental","pubTime":"2025-02-14 20:30","pubTimestamp":1739536200,"startTime":"0","endTime":"0","summary":"The company is on track to complete the interim data analysis before the end of Q1 2025 and to submit the findings to the U.S. Food And Drug Administration (FDA)PHILADELPHIA, Feb.  14, 2025  (GLOBE NE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/14/3026584/0/en/Medicus-Pharma-Provides-Update-on-SKNJCT-003-Phase-2-Clinical-Study-for-the-Treatment-of-Nodular-Basal-Cell-Carcinoma-BCC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCC","BK4567","BK4139","BK4104","MDCX"],"gpt_icon":0},{"id":"2510386885","title":"Medicus Pharma enters SEPA, intends to voluntarily delist from TSX","url":"https://stock-news.laohu8.com/highlight/detail?id=2510386885","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510386885?lang=en_us&edition=fundamental","pubTime":"2025-02-11 21:07","pubTimestamp":1739279258,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) has entered into a Standby Equity Purchase Agreement with YA II PN, an investment fund managed by Yorkville Advisors Global. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-enters-sepa-intends-to-voluntarily-delist-from-tsx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-enters-sepa-intends-to-voluntarily-delist-from-tsx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPA","MDCX","BK4139"],"gpt_icon":0},{"id":"2510833613","title":"Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510833613","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510833613?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:30","pubTimestamp":1739277000,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital MarketTORONTO and  PHILADELPHIA, Feb.  11, 2025  (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"Company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/11/3024067/0/en/Medicus-Pharma-Ltd-Enters-into-Standby-Equity-Purchase-Agreement-and-Announces-Intention-to-Voluntarily-Delist-from-the-TSX-Venture-Exchange-TSXV.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","BK4588","BK4585",".IXIC","EQR","TQQQ","USAW.SI","QLD","BK4215","NQmain","MDCX","BK4139","USJW.SI","NVIW.SI","SQQQ","TSYW.SI","PSQ","QID"],"gpt_icon":1},{"id":"2494386836","title":"Medicus Pharma Ltd. Announces Change of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494386836?lang=en_us&edition=fundamental","pubTime":"2024-12-26 21:27","pubTimestamp":1735219631,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($TSE:MDCX) ) has provided an announcement. Medicus Pharma Ltd. has announced a change in its auditing firm, with MNP LLP resi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-ltd-announces-change-of-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-ltd-announces-change-of-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2493070749","title":"Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success with Favorable Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2493070749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493070749?lang=en_us&edition=fundamental","pubTime":"2024-12-24 19:25","pubTimestamp":1735039514,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd (MDCX) has received a new Buy rating, initiated by Brookline Capital Markets analyst, Kumaraguru Raja. Kumaraguru Raja’s rating ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/medicus-pharma-ltd-innovative-d-mna-product-positions-company-for-success-with-favorable-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/medicus-pharma-ltd-innovative-d-mna-product-positions-company-for-success-with-favorable-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNA","MDCX"],"gpt_icon":0},{"id":"2493470956","title":"Medicus Pharma initiated with a Buy at Brookline","url":"https://stock-news.laohu8.com/highlight/detail?id=2493470956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493470956?lang=en_us&edition=fundamental","pubTime":"2024-12-24 18:10","pubTimestamp":1735035014,"startTime":"0","endTime":"0","summary":"Brookline analyst Kumaraguru Raja initiated coverage of Medicus Pharma (MDCX) with a Buy rating and $12 price target Medicus is advancing D-MNA, a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-initiated-with-a-buy-at-brookline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-initiated-with-a-buy-at-brookline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139","BK4211","BRKL"],"gpt_icon":0},{"id":"2490383579","title":"Medicus Pharma Eyes Veterinary Market with FDA Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2490383579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490383579?lang=en_us&edition=fundamental","pubTime":"2024-12-12 21:07","pubTimestamp":1734008854,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd (TSE:MDCX) has released an update. Medicus Pharma Ltd. has received a Minor Use in Major Species Designation from the FDA for th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-eyes-veterinary-market-with-fda-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-eyes-veterinary-market-with-fda-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2490807220","title":"Medicus Pharma announcs its INAD received MUMS from U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807220?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:36","pubTimestamp":1734006992,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) announces that its Investigational New Animal Drug, INAD, has received Minor Use in Major Species Designation, MUMS, from the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-announcs-its-inad-received-mums-from-u-s-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-announcs-its-inad-received-mums-from-u-s-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2490807493","title":"Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807493","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807493?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":"Company to Submit Product Development Plan to Treat External Squamous Cell Carcinoma (SCC) in HorsesTORONTO and PHILADELPHIA, Dec.  12, 2024  (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TS","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/12/2996094/0/en/Medicus-Pharma-Ltd-Announces-Minor-Use-MUMS-Designation-from-the-FDA-for-Doxorubicin-Containing-Microneedle-Array-D-MNA-Patch.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNA","SCC","BK4139","MDCX"],"gpt_icon":0},{"id":"2488680675","title":"Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2488680675","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488680675?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:30","pubTimestamp":1733142600,"startTime":"0","endTime":"0","summary":"Provides Update on SKNJCT-003 Phase 2 Clinical Study for Treatment of Nodular Basal Cell Carcinoma (BCC) Currently Underway in United StatesTORONTO, Dec.  02, 2024  (GLOBE NEWSWIRE) -- Medicus Pharma ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989703/0/en/Medicus-Pharma-Ltd-Announces-Collaboration-Agreement-to-Expand-Phase-2-Clinical-Study-in-Asia-Pacific-Region.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4104","BK4139","BCC","BK4567"],"gpt_icon":0},{"id":"2486768128","title":"MDCX: Medicus Pharma 3Q 2024 Financial Results Reported; Stock Now Trades Both in Canada and on Nasdaq After Completing an IPO in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486768128","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486768128?lang=en_us&edition=fundamental","pubTime":"2024-11-27 18:37","pubTimestamp":1732703820,"startTime":"0","endTime":"0","summary":"On November 22, 2024, Medicus Pharma   reported financial results for the third quarter ending September 30, 2024.IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq. On November 14, 2024, Medicus Pharma Ltd. closed an IPO  in the United States. Gross proceeds from the IPO were approximately US$4.0 million and consisted of 970,000 Units at a price of US$4.125 per Unit. Each Unit is comprised of 1 common share & one 5-year warrant exercisable at US$4.64 per share. The stock issued as part of the IPO trades under the same ticker in the U.S.  as in Canada , namely MDCX. The warrants are trading under the ticker MDCXW.Net proceeds from the IPO will help fund the Phase 2 proof of concept clinical trial for treatment of basal cell carcinoma using its doxorubicin tip loaded Dissolvable Microneedle Array SkinJect transdermal skin patch. Some of the net proceeds may be used to extend the Phase 2 trial to a pivotal trial and/or to expand to clinical trials covering other","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GPhWNXzS7IGuQ6RUn6IU3g--~B/aD00OTg7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/scr.zacks.com/a59bb4b8035314b835406479c0334d67","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GPhWNXzS7IGuQ6RUn6IU3g--~B/aD00OTg7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/scr.zacks.com/a59bb4b8035314b835406479c0334d67"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mdcx-medicus-pharma-3q-2024-103700902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","LU2210150020.SGD","PSQ","BK4139","LU2210149790.SGD","BK4104","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","BK4567","QLD","IE00BKPKM429.USD","TQQQ","MNQmain","SQQQ","MDCXW","NDAQ","BK4112","NQmain","QID","BK4585","BK4588","IE00B3QW5Z07.USD","MDCX","BCC"],"gpt_icon":1},{"id":"2486084800","title":"Medicus Pharma Ltd. Expands with Strategic Takeover","url":"https://stock-news.laohu8.com/highlight/detail?id=2486084800","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486084800?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:30","pubTimestamp":1732541400,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd (TSE:MDCX) has released an update. Medicus Pharma Ltd., formerly Interactive Capital Partners Corporation, has undergone a signi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-ltd-expands-with-strategic-takeover?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-ltd-expands-with-strategic-takeover?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2486087490","title":"V.MDCX: Medicus Pharma Has Begun Trading on Nasdaq under the ticker MDCX after Completing an IPO in the U.S. The SKNJCT-003 Phase 2 clinical trial continues.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087490","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486087490?lang=en_us&edition=fundamental","pubTime":"2024-11-25 17:13","pubTimestamp":1732525980,"startTime":"0","endTime":"0","summary":"IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq. Net proceeds from the IPO will help fund the Phase 2 proof of concept clinical trial for treatment of basal cell carcinoma using its doxorubicin tip loaded Dissolvable Microneedle Array SkinJect transdermal skin patch. Some of the net proceeds may be used to extend the Phase 2 trial to a pivotal trial and/or to expand to clinical trials covering other non-melanoma skin diseases. We estimate that the net proceeds from the IPO to be approximately US$3.64 million. Maxim Group LLC acted as the manager and Brookline Capital Markets  acted as co-manager.In connection with the IPO, Medicus Pharma consolidated its common shares on a 2-to-1 basis on October 28th.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wP83yA2Zhb6u6_hqvl8amw--~B/aD03OTY7dz0xNjkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/5c4fdbf9ad2737b4f4d8e625a45fa31a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wP83yA2Zhb6u6_hqvl8amw--~B/aD03OTY7dz0xNjkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/5c4fdbf9ad2737b4f4d8e625a45fa31a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/v-mdcx-medicus-pharma-begun-091300702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ","PSQ","MDCXW","BK4112","SQQQ","QID","BK4588","QLD","IE00B64PRP62.GBP","TQQQ","IE00BGHQF748.EUR","BK4104","NQmain","BK4567","BCC","BK4585",".IXIC","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2210150020.SGD","MDCX","MNQmain","LU2095319765.USD","IE00BKPKM429.USD","BK4139"],"gpt_icon":1},{"id":"2484629090","title":"Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629090","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484629090?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:30","pubTimestamp":1731933000,"startTime":"0","endTime":"0","summary":"Promotes Edward Brennan, MD, FACS to Chief Scientific Officer & Head of R&D Program. TORONTO and PHILADELPHIA, Nov. 18, 2024  -- Medicus Pharma Ltd   is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical Officer.Most recently, Dr. Mehmud was the Senior Vice President, Data Generation and Scientific Communications in Worldwide Global Medical Affairs at GlaxoSmithKline , which included leadership of medical affairs sponsored and supported, interventional and non-interventional clinical trials. Before GSK, Dr. Mehmud was with Pfizer Inc., where he served in various roles including as Vice President and Worldwide Medical Franchise Head for Precision Medicine and Early Oncology Development, advancing the precision medicine oncology portfolio in a variety of tumor types, and supporting early-stage oncology projects moving from early clinical development to full development and market readiness, effectively bridging scientific innovation with commercial strategy.Dr. Meh","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","MD","IE00BBT3K403.USD","BK4588","IE00B19Z3B42.SGD","MRCP","SG9999002232.USD","BK4581","BK4007","LU0058720904.USD","IE00BLSP4452.SGD","LU1894683264.USD","IE0002270589.USD","BK4533","LU0225771236.USD","LU1057294990.SGD","IE000M9KFDE8.USD","PFE","BK4196","MDCX","SG9999003800.SGD","GSK.UK","BMS","LU1829250122.USD","LU0985481810.HKD","BK4532","LU1066051498.USD","IE00BLSP4239.USD","IE00B19Z3581.USD","LU1894683348.USD","LU0306806265.USD","BK4585","BK4568","SG9999013999.USD","LU0122379950.USD","SGXZ57979304.SGD","BK4534","LU1066053197.SGD","LU0289739699.SGD","LU0868494617.USD","LU1883839398.USD","SG9999001176.SGD","LU0306807586.USD","BK4592","LU1023059063.AUD","GSK","LU0170899867.USD","LU0321505868.SGD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2483532283","title":"Medicus Pharma Closes $4M IPO, Trades on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2483532283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483532283?lang=en_us&edition=fundamental","pubTime":"2024-11-16 07:10","pubTimestamp":1731712204,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd (TSE:MDCX) has released an update. Medicus Pharma Ltd has successfully closed its $4 million initial public offering in the U.S....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-closes-4m-ipo-trades-on-nasdaq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-closes-4m-ipo-trades-on-nasdaq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2210149790.SGD","LU2095319765.USD","BK4585","QID","IE00B64PRP62.GBP","MDCX",".IXIC","NDAQ","PSQ","LU2210150020.SGD","NQmain","IE00BKPKM429.USD","QLD","SQQQ","BK4112","TQQQ","MNQmain","BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":2,"totalSize":35}]}}